Cardiac Resynchronization Therapy in Ischemic Versus Nonischemic Cardiomyopathy: Patient-Level Meta-Analysis of 7...

Area of Science:

• Cardiology
• Heart Failure Management
• Medical Interventions

Background:

• Conflicting data exist on cardiac resynchronization therapy (CRT) effectiveness in nonischemic cardiomyopathy (NICM) versus ischemic cardiomyopathy (ICM).
• Understanding the impact of cardiomyopathy etiology on CRT outcomes is crucial for patient management.

Purpose of the Study:

• To conduct a meta-analysis of clinical trials to determine the association between cardiomyopathy etiology and clinical/echocardiographic outcomes following CRT.
• To evaluate if CRT outcomes differ between patients with NICM and ICM.

Main Methods:

• Meta-analysis of 7 clinical trials involving patient-level data.
• Bayesian Hierarchical Weibull survival regression for time-to-event outcomes (all-cause death, heart failure hospitalization).
• Linear regression for echocardiographic measurements.

Main Results:

• CRT significantly increased time to heart failure hospitalization or all-cause death, irrespective of cardiomyopathy etiology.
• No significant difference in CRT's effect on mortality or hospitalization was observed between NICM and ICM patients.
• While CRT showed greater improvements in left ventricular ejection fraction and dimensions in NICM patients, its overall clinical benefit was consistent across etiologies.

Conclusions:

• Cardiac resynchronization therapy (CRT) improves clinical outcomes, including reduced mortality and hospitalization, independently of cardiomyopathy etiology.
• Greater echocardiographic improvements were noted in nonischemic cardiomyopathy patients, suggesting potential differences in response mechanisms.
• Further research is needed to optimize patient selection for CRT to maximize individual benefits.